Literature DB >> 17698786

GNE protein expression and subcellular distribution are unaltered in HIBM.

S Krause1, A Aleo, S Hinderlich, L Merlini, I Tournev, M C Walter, Z Argov, S Mitrani-Rosenbaum, H Lochmüller.   

Abstract

Mutations in GNE encoding UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) cause hereditary inclusion body myopathy (HIBM). To define the role of GNE mutations in HIBM pathogenesis, GNE protein expression was analyzed. GNE protein is expressed at equal levels in HIBM patients and normal control subjects. Immunofluorescence detection of GNE did not reveal any mislocalization of GNE in skeletal muscle. We conclude that impaired GNE function, not lack of expression, may be the key pathogenic factor in HIBM. For diagnostic purposes, direct genetic analysis of the GNE gene in patients with IBM will remain the mainstay and is not aided by immunohistochemistry or immunoblotting using antibodies against the GNE protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698786     DOI: 10.1212/01.wnl.0000267426.97138.fd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Hereditary inclusion body myopathy: a decade of progress.

Authors:  Marjan Huizing; Donna M Krasnewich
Journal:  Biochim Biophys Acta       Date:  2009-07-24

2.  Clinical, genetic, and pathological characterization of GNE myopathy in China.

Authors:  Xiao-Qing Lv; Ling Xu; Peng-Fei Lin; Chuan-Zhu Yan
Journal:  Neurol Sci       Date:  2022-02-09       Impact factor: 3.307

3.  Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.

Authors:  Thomas Paccalet; Zoé Coulombe; Jacques P Tremblay
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

4.  The Interaction of UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) and Alpha-Actinin 2 Is Altered in GNE Myopathy M743T Mutant.

Authors:  Avi Harazi; Michal Becker-Cohen; Hagit Zer; Ofra Moshel; Stephan Hinderlich; Stella Mitrani-Rosenbaum
Journal:  Mol Neurobiol       Date:  2016-03-29       Impact factor: 5.590

5.  Correction of the Middle Eastern M712T mutation causing GNE myopathy by trans-splicing.

Authors:  Tzukit Tal-Goldberg; Stéphanie Lorain; Stella Mitrani-Rosenbaum
Journal:  Neuromolecular Med       Date:  2013-11-22       Impact factor: 3.843

Review 6.  The hereditary inclusion body myopathy enigma and its future therapy.

Authors:  Zohar Argov; Stella Mitrani-Rosenbaum
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 7.  Perspectives on distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy: contributions from an animal model. Lack of sialic acid, a central determinant in sugar chains, causes myopathy?

Authors:  M C V Malicdan; S Noguchi; I Nishino
Journal:  Acta Myol       Date:  2007-12

Review 8.  UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis.

Authors:  Stephan Hinderlich; Wenke Weidemann; Tal Yardeni; Rüdiger Horstkorte; Marjan Huizing
Journal:  Top Curr Chem       Date:  2015

9.  Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.

Authors:  Anagha P Phadke; Chris Jay; Salina J Chen; Courtney Haddock; Zhaohui Wang; Yang Yu; Derek Nemunaitis; Gregory Nemunaitis; Nancy S Templeton; Neil Senzer; Phillip B Maples; Alex W Tong; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-05-08

10.  Hereditary Inclusion Body Myopathy (HIBM2).

Authors:  Chris M Jay; Nick Levonyak; Gregory Nemunaitis; Phillip B Maples; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.